Google’s life sciences team is about to become a standalone company. Formerly part of the tech giant’s secretive research organisation Google X, the company has now confirmed speculation that it’s to be spun off into a company of its own under Alphabet.
Co-founder Sergey Brin wrote in a blog post today that the goal would remain unchanged despite the change in structure:
They’ll continue to work with other life sciences companies to move new technologies from early stage R&D to clinical testing — and, hopefully — transform the way we detect, prevent, and manage disease.
The team has previously developed glucose-monitoring contact lenses for diabetics. Their work may seem somewhat opaque, but the stated goal is to develop more “proactive” healthcare, with everything from engineers to oncologists working together.
Andy Conrad, who was head of Google X Life Sciences, will be taking on the role as chief executive of the new company.
This spin-off has been rumoured since the announcement of Google’s restructuring into Alphabet, but the official announcement wasn’t made until today.